Search Trials

Order


Status


176 results


Recruiting

Start date: Dec. 1, 1998

Hydatidiform mole (HM) is the product of an aberrant human pregnancy in which there is abnormal embryonic development and abnormal proliferation of placental villi. The incidence of HM varies between … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: Oct. 1, 2002

Aicardi syndrome is a sporadic X-linked dominant, presumably male-lethal, neurodevelopmental disorder. It was initially characterized by agenesis of the corpus callosum, neuronal migration defects, eye abnormalities (chorioretinal lacunae, colobomas of … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: June 1, 2003

This current protocol was established as part of an NIDDK initiative to further explore genetic factors associated with IBD. Specifically, the investigators are interested in identifying the genetic, environment and … Read More

BCM Role: Collaborator

Recruiting

Start date: Feb. 1, 2008

The Study is designed to collect information about adverse events that occur in children undergoing anesthesia in participating hospitals. Demographic information will be collected on all anesthetics. An analysis of … Read More

BCM Role: Collaborator

Recruiting

Start date: July 1, 2009

To prepare the lymphoma, MM or CLL specific T cells investigators will take 240 ml (up to 16 tablespoonfuls)of blood from the patient. This would be drawn as 2 (two) … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: July 1, 2010

This is a quality improvement project to evaluate the current standard of care of nutritional management for very low birth weight infants receiving donor human milk products in the NICU … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: Oct. 1, 2010

Participation in this project will last approximately one year with follow-up exams. Before treatment can begin, stem cells will be collected from the donor (a close relative) that has been … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: Nov. 1, 2011

The continuous progresses of medical science and technology and the improvement of life conditions have increased the life expectancy in industrialized countries: the result is the progressive population aging [UN, … Read More

BCM Role: Collaborator

Recruiting

Start date: Jan. 1, 2012

The patient will give blood to make TAA-specific cytotoxic T cells in the lab. These cells will be grown and frozen. If the TAA-specific cytotoxic T cells can be made, … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: Jan. 1, 2012

The aims of this study is to determine the effects of treatment with doxazosin XL 16 mg/d combined with virtual reality (VR) exposure therapy on Post Traumatic Stress Disorder. The … Read More

BCM Role: Lead Sponsor